 |
|
|
| |
Pharmacokinetics (PK) of once-daily dolutegravir (DTG) and
elvitegravir/cobicistat (EVG/COBI) following drug cessation
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
26-28 May, Washington DC, USA
Emilie Elliot1, Alieu Amara2, Akil Jackson1,2, Graeme Moyle1, Laura Else2, Saye Khoo2, David Back2, Andrew Owen2, Marta Boffito1,3
1St Stephen's Centre, Chelsea and Westminster Hospital, London, UK; 2University of Liverpool, Liverpool, UK; 3Imperial College, London
|
| |
|
|
|
|
|
